Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-03-19 00:00:00 ET · period of report 2024-03-15 · accession 0001415889-24-008520 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-19 | 2024-03-15 | PCVX | Wassil Jim | COO | A - Grant | $0.00 | +4,099 | 222.8K | +2% | $0 | |
| 2024-03-19 | 2024-03-15 | PCVX | Wassil Jim | COO | F - Tax | $69.70 | -1,484 | 221.3K | -0.7% | -$103.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | A | A | 4,099 | $0.00 | 222,773 | D | — | — | (F1) Represents the number of shares of Common Stock underlying restricted stock units ("RSUs") issued in lieu of a cash bonus by election of the Reporting Person, such election available to all of Issuer's senior management. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs are fully vested upon the date of grant. |
| 2 | Common | Common Stock | 2024-03-15 | F | D | 1,484 | $69.70 | 221,289 | D | — | — | (F2) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |